Folks in Congress are making incredible amounts of money trading in the stock market. In fact, Quiver Quantitative reports that stocks bought and sold by members of Congress and their families have increased in value by almost 45 percent this past year.

Think this qualifies as insider trading? Charles is joined by Congressman Chip Roy (R-TX), who is working across the aisle on a bill to ban members of Congress from trading stocks, calling it “a pretty simple conflict of interest.”

Learn more about your ad choices. Visit podcastchoices.com/adchoices

The controversy and debate over last week’s negative jobs report has gone on and on. Charles says if you look closer, the efforts to secure our borders have already paid dividends for working Americans.

Charles is joined by FOX News’ Harris Faulkner to discuss her conversation with Border Czar Tom Homan about the financial and municipal strain illegal migrants put on the country.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Stalling growth and hot prices have complicated the Fed’s 'soft-landing' goal. Charles says, as U.S. markets rebound from last week, why can’t Fed Chair Powell cut rates and take the victory? 

Charles and his guest, Stonex chief market strategist Kathryn Rooney Vera, discuss the highly political nature of the Fed, Kathryn’s belief that rate cuts are coming, and the ongoing U.S. exceptionalism trade.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Those on the political left are attacking Sydney Sweeney’s latest American Eagle ad, where she is clad in denim and she says she’s got “great jeans.” Progressives online are melting down, calling the harmless ad a “Nazi dog whistle.”

Charles speaks with ‘Mansion Global’ host Katrina Campins & The Federalist correspondent Brianna Lyman about why Gen Z treats women embracing femininity as counterculture and why the left is creating noise about this.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Charles is looking at the latest data on price changes and the labor market, and he’s coming to one conclusion: we are not due for the same “earth-shattering” price spikes we saw under the Biden administration.

So why does Jay Powell need to see this economy get hit before he steps up and calls for a cut? Charles talks to FOX Business’ Larry Kudlow about dissent at the Fed and how the Fed Chair took his “eye off the ball.”

Learn more about your ad choices. Visit podcastchoices.com/adchoices

After Tuesday's China trade talks, Charles dismisses media claims that the Trump Administration “chickened out,” calling it standard negotiation. Charles notes China replaced its top negotiator in April with a moderate to ease tensions.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Charles emphasizes the importance of respecting market trends rather than pushing against them, calling out how many on Wall Street continue to bet against momentum, with poor results. 

FOX News Contributor and President of Kaltbaum Capital Management, Gary Kaltbaum, breaks down timeless investing principles like "don’t fight the tape," exploring which have stood the test of time and which no longer apply in today’s evolving market. Later, they uncover promising opportunities in sectors like homebuilders and home improvement, which are showing signs of sustained upward movement.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Charles pushes back on the doom-and-gloom headlines and their impact on consumer confidence and financial choices. From booming tech and AI to strong equity performance, he makes the case for continued American economic strength. 

Rob Luna, CEO of Luna Venture Partners, joins to share why he's bullish on America’s future, crediting innovation and entrepreneurship as the real growth drivers.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Breakthroughs in anti-aging biotech could create a multi-trillion-dollar industry, as living longer becomes a top priority for an increasing number of Americans.

Charles Payne is joined by longevity biotech co-founder Marc Bernegger, whose company Maximon focuses on making healthier aging a reality. Marc shares a few technological advancements (e.g., GLP-1s), which factors are driving extended lifespans, and the ripe opportunity to invest in biotech before it becomes a "mass phenomenon."

Catch his town hall special, "Unbreakable Investor: Live Forever and Prosper" on FOX Business this Thursday, July 24, at 2 PM Eastern.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

We stand at a pivotal moment for health in our nation, as President Trump's administration has elevated the "Make America Healthy Again" movement to a cornerstone of their agenda.

As Americans seek options for longer, healthier lives, technology races to meet that demand. Charles Payne previews the innovations in longevity and biotechnology poised to reshape our future and revolutionize our medicine.

Catch his town hall special, "Unbreakable Investor: Live Forever and Prosper" on FOX Business this Thursday, July 24, at 2 PM Eastern.

Learn more about your ad choices. Visit podcastchoices.com/adchoices